Literature DB >> 12009329

Alternative splicing of transcripts for the alpha 3 chain of mouse collagen VI: identification of an abundant isoform lacking domains N7-N10 in mouse and human.

Marie Dziadek1, Janette S Kazenwadel, Jaqueline A Hendrey, Te-Cheng Pan, Rui-Zhu Zhang, Mon-Li Chu.   

Abstract

Three distinct alpha chains form the collagen VI monomer, the alpha 3(VI) chain being much larger than the alpha 1(VI) and alpha 2(VI) chains. The alpha 3(VI) chain has 10 von Willebrand Factor type A domains of approximately 200 amino acids at the N-terminus (N1-N10) compared with only one such domain in the alpha 1(VI) and alpha 2(VI) chains. Domains N10, N9, N7 and N3 of the alpha 3(VI) chain are subject to alternative splicing in chick and/or human tissues, indicating the possibility of isoforms that have different functions depending on which N-terminal domains are included or excluded. In this study we have PCR amplified and sequenced mouse alpha 3(VI) cDNA encoding the N2-N10 domains. By reverse transcription-PCR using oligonucleotides spanning different regions of the cDNA we have undertaken a comprehensive analysis of alternative splicing of the alpha 3(VI) mRNA in embryonic and adult mouse tissues. We demonstrate that domains N10, N9 and N7 are also subject to alternative splicing in mouse tissues and in addition identify an abundant novel variant transcript that lacks all four N-terminal domains (N7-N10) in mouse tissues and human cells. We also identify less abundant transcripts that lack a large part of the N3 domain, and transcripts lacking the entire N5 domain. Using specific RNase protection assays we show that the shorter transcripts containing domains (N8+N7+N6), (N8+N6) and N6 are present at higher levels than transcripts containing the N10 and/or N9 domains, with tissue-specific variation in the levels of variant transcripts. These studies demonstrate a larger range of collagen VI protein variants than previously described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009329     DOI: 10.1016/s0945-053x(02)00009-4

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  6 in total

Review 1.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

2.  Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  A K Lampe; D M Dunn; A C von Niederhausern; C Hamil; A Aoyagi; S H Laval; S K Marie; M-L Chu; K Swoboda; F Muntoni; C G Bonnemann; K M Flanigan; K M D Bushby; R B Weiss
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

3.  Collagen VI, conformation of A-domain arrays and microfibril architecture.

Authors:  Nicola Beecher; Alan M Roseman; Thomas A Jowitt; Richard Berry; Helen Troilo; Richard A Kammerer; C Adrian Shuttleworth; Cay M Kielty; Clair Baldock
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

Review 4.  The Biological Role of the Collagen Alpha-3 (VI) Chain and Its Cleaved C5 Domain Fragment Endotrophin in Cancer.

Authors:  Jingya Wang; Wensheng Pan
Journal:  Onco Targets Ther       Date:  2020-06-22       Impact factor: 4.147

5.  Structural and compositional diversity of fibrillin microfibrils in human tissues.

Authors:  Alexander Eckersley; Kieran T Mellody; Suzanne Pilkington; Christopher E M Griffiths; Rachel E B Watson; Ronan O'Cualain; Clair Baldock; David Knight; Michael J Sherratt
Journal:  J Biol Chem       Date:  2018-02-16       Impact factor: 5.157

6.  Defining the hierarchical organisation of collagen VI microfibrils at nanometre to micrometre length scales.

Authors:  Alan R F Godwin; Tobias Starborg; Michael J Sherratt; Alan M Roseman; Clair Baldock
Journal:  Acta Biomater       Date:  2016-12-10       Impact factor: 8.947

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.